Batch Release and CMO campaign Coordinator

This role has responsibility to ensure supply plans are met by driving batch release activities and specific Contract Manufacturing Organisations (CMO) activities across multiple products and markets. The role also ensures up to date status and outlook for supply from the current campaign is available and clearly communicated to the organization on an ongoing basis. The role is highly cross-functional with network-wide supply management responsibility, working with Global and Site Supply Chain managers and Quality Operations team members within CSL Seqirus and 3rd party CMOs.

Key responsibility is to manage cross functionally all the activities needed to ensure batches are released in alignment with supply plans. The role oversees these activities for all Fluad and Flucelvax EU/ROW markets. The role also ensures completion of data inputs across multiple functions in site and CMO campaign tracking tools to ensure accurate reporting of progress and to highlight any issues. This is a key tracking and reporting mechanism that has multiple impacts across all functions, CSL Seqirus sites and CMOs to achieve successful campaign outcomes. Role needs to resolve issues and analyse complex interdependencies, discussing these with senior stakeholders to ensure supply plan can be adhered to. High usage of MS Excel and SAP.

Education: A bachelor’s degree in Scientific or Commercial discipline, 2+ years’ experience in a relevant field such as supply chain, manufacturing, or data analysis, with proven ability to manage complex tasks, collaborate across teams, and work independently with strong attention to detail. Knowledge of pharmaceutical best practices, MS Excel and SAP.

Different qualifications or responsibilities may apply based on local legal and/or educational requirements.

Refer to local job documentation where applicable.

About CSL Seqirus

CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

 To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.

Watch our ‘On the Front Line’ video to learn more about CSL Seqirus